Brain Areas Involved in Modulating the Immune Response Participating in Hypertension and Its Target Organ Damage

Marialuisa Perrotta1, Daniela Carnevale1,2

  • 1Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.

Insights

Hypertension involves cardiovascular, neurogenic, and immune system dysregulation. This review explores how brain areas modulate immune responses crucial for managing high blood pressure.

Area of Science:

  • Cardiovascular Science
  • Neuroimmunology
  • Hypertension Research

Background:

  • Hypertension is a complex disease influenced by cardiovascular, neurogenic, and immune factors.
  • Traditionally recognized mechanisms include autonomic nervous system (ANS) dysregulation and renin-angiotensin system activation.
  • Emerging evidence highlights the significant role of immune activation and inflammation in hypertension development and persistence.

Purpose of the Study:

  • To re-evaluate hypertension's pathophysiology by considering interactions between established risk factors and the immune system.
  • To explore the critical role of neuroimmune interactions in hypertension.
  • To summarize research on how specific brain regions influence immune responses involved in hypertension.

Main Methods:

  • Review of existing scientific literature and studies.
  • Analysis of research on central nervous system (CNS) control of cardiovascular functions.
  • Examination of the interplay between the ANS, brain, and peripheral immune responses.

Main Results:

  • Central nervous system areas regulating cardiovascular functions possess abundant Angiotensin II receptors.
  • These brain regions are vital in mediating peripheral ANS and immune responses.
  • The ANS acts as a key mediator between the brain and peripheral systems for blood pressure regulation.

Conclusions:

  • Neuroimmune interactions play a critical role in the pathogenesis of hypertension.
  • Specific brain areas can modulate immune responses implicated in high blood pressure.
  • Understanding these neuroimmune pathways is essential for developing novel hypertension therapies.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
215
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
5.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
609
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
127